{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:12:58Z","timestamp":1791943978255,"version":"4.3.4"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jcf.2026.08.003","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T09:28:51Z","timestamp":1787390931000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Incidence, prevalence, and survival of persons living with advanced cystic fibrosis lung disease in the United States"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6396-2379","authenticated-orcid":false,"given":"Jonathan V","family":"Todd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2309-368X","authenticated-orcid":false,"given":"Kathleen J.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5968-8384","authenticated-orcid":false,"given":"Erin","family":"Tallarico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Thaxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Beres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4332-4112","authenticated-orcid":false,"given":"Whitney","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8408-6371","authenticated-orcid":false,"given":"Albert","family":"Faro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Cromwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jcf.2026.08.003_bib0001","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jcf.2020.02.015","article-title":"Cystic fibrosis foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease","volume":"19","author":"Kapnadak","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.08.003_bib0002","unstructured":"Cystic Fibrosis Foundation, 2025. Cystic Fibrosis Foundation Patient Registry 2024 Annual Data Report. https:\/\/www.cff.org\/media\/38406\/download [Date last accessed: 17 February 2026]."},{"issue":"3","key":"10.1016\/j.jcf.2026.08.003_bib0003","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcf.2019.03.002","article-title":"Lung transplant referral for individuals with cystic fibrosis: cystic fibrosis Foundation consensus guidelines","volume":"18","author":"Ramos","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2026.08.003_bib0004","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jcf.2023.02.009","article-title":"Cystic fibrosis prevalence in the United States and participation in the cystic fibrosis foundation patient registry in 2020","volume":"22","author":"Cromwell","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10.1016\/j.jcf.2026.08.003_bib0005","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1513\/AnnalsATS.201511-781OC","article-title":"The Cystic fibrosis foundation patient registry. design and methods of a National observational disease Registry","volume":"13","author":"Knapp","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.jcf.2026.08.003_bib0006","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-0042-1758731","article-title":"Advanced cystic fibrosis lung disease and lung transplantation in the era of cystic fibrosis transmembrane conductance regulator modulators","volume":"44","author":"O'Carroll","year":"2023","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcf.2026.08.003_bib0007","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1164\/rccm.202011-4153OC","article-title":"Rapid improvement after starting elexacaftor-tezacaftor-ivacaftor in patients with cystic fibrosis and advanced pulmonary disease","volume":"204","author":"Burgel","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jcf.2026.08.003_bib0008","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1513\/AnnalsATS.202405-451RL","article-title":"Reduction in 3-year risk of death or lung transplant for individuals with advanced cystic fibrosis lung disease treated with elexacaftor\/tezacaftor\/ivacaftor","volume":"22","author":"Love","year":"2025","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.jcf.2026.08.003_bib0009","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.athoracsur.2023.07.052","article-title":"Racial disparities in waiting list outcomes of patients listed for lung transplantation","volume":"117","author":"Florissi","year":"2024","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"10.1016\/j.jcf.2026.08.003_bib0010","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.healun.2021.06.004","article-title":"Gender and racial disparities in lung transplantation in the United States","volume":"40","author":"Riley","year":"2021","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.jcf.2026.08.003_bib0011","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.0572","article-title":"Socioeconomic differences in navigating access to lung transplant","volume":"8","author":"Lehr","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.jcf.2026.08.003_bib0012","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1164\/rccm.201205-0949OC","article-title":"Disparities in access to lung transplantation for patients with cystic fibrosis by socioeconomic status","volume":"186","author":"Quon","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jcf.2026.08.003_bib0013","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jcf.2015.11.005","article-title":"Predictors of non-referral of patients with cystic fibrosis for lung transplant evaluation in the United States","volume":"15","author":"Ramos","year":"2016","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326037173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326037173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T20:12:09Z","timestamp":1787515929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326037173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":13,"alternative-id":["S1569199326037173"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.08.003","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence, prevalence, and survival of persons living with advanced cystic fibrosis lung disease in the United States","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}